Menopause is a natural biological transition, but for many women it is accompanied by significant symptoms that affect sleep, mood, metabolism, body composition, cognitive clarity, and overall quality of life. Hormonal shifts during perimenopause and menopause can create wide-ranging physiologic changes.
This page explains what menopause is, why symptoms vary widely, and how LiteWell evaluates and addresses menopause-related concerns using a structured, physician-led, data-driven approach.
Satisfied with our services
Menopause is defined as the absence of menstrual cycles for 12 consecutive months and reflects a decline in ovarian hormone production, particularly estrogen and progesterone. The transition period leading up to menopause, known as perimenopause, may last several years and is often when symptoms are most disruptive.
Hormonal fluctuations during this phase can affect thermoregulation, sleep architecture, mood stability, cardiometabolic health, bone density, and body composition.
Many women are told their symptoms are simply part of aging and may not receive a comprehensive evaluation. Standard laboratory testing may not fully assess estrogen balance, progesterone status, metabolic health, thyroid function, or cardiovascular risk.
Menopause-related symptoms often overlap with metabolic dysfunction, sleep disorders, stress physiology, and thyroid imbalance, requiring careful clinical interpretation rather than isolated lab review.
LiteWell evaluates menopause-related symptoms through a comprehensive clinical process that integrates laboratory testing, symptom analysis, medical history, and physician interpretation.
Most patients begin with a Free Medical Fit Call, followed by the Premier Discovery Intake when appropriate. This structured intake provides objective data necessary to assess hormonal balance, metabolic health, and cardiovascular risk factors.
– Estradiol levels
– Progesterone levels when clinically indicated
– Thyroid function panel
– Testosterone levels when appropriate
– Lipid profile and cardiovascular risk markers
– Inflammatory markers such as hs-CRP
– Metabolic markers including fasting glucose and insulin
LiteWell offers physician-supervised services designed to evaluate and address menopause-related symptoms within a structured, individualized care pathway.
(when metabolic dysfunction is present)
For appropriate patients, LiteWell develops individualized strategies to support hormonal balance, metabolic health, and long-term wellness during menopause. When clinically indicated, physician-supervised hormone replacement therapy may be considered as part of a comprehensive care plan.
All treatment decisions are individualized, physician-led, and guided by objective laboratory findings and risk assessment.
The average age of menopause is approximately 51, though perimenopause symptoms may begin several years earlier.
In some cases, clinical history is sufficient, but laboratory testing can help clarify hormonal status and guide management decisions.
Hormone therapy may be appropriate for selected patients after careful risk assessment. Individual medical history and cardiovascular risk must be considered.
Hormonal changes during menopause may contribute to changes in body composition, including increased abdominal fat.
Post-menopausal women may experience changes in lipid profiles and cardiovascular risk markers, which should be monitored.
Many women report cognitive changes during perimenopause and menopause, often associated with hormonal fluctuations and sleep disruption.
Most patients begin with a Free Medical Fit Call, followed by the Premier Discovery Intake if appropriate.
If menopause-related symptoms are affecting daily function or quality of life, a structured medical evaluation may help clarify contributing factors and guide evidence-based next steps. LiteWell provides a physician-led approach focused on hormonal balance and long-term health optimization.
